Körber Pharma dedicates October & November to cell and gene therapy
Cutting-edge therapies have proven to be the new frontier of modern medicine and we are honored to support bringing lifesaving medicines to the market with our Werum PAS-X MES solution. Körber Pharma’s software experts support 100% of FDA-approved CAR-T products as well as many companies in earlier phase clinical manufacturing.
In the coming weeks we will be sharing many resources around manufacturing personalized medicines including e-books, web seminars, white papers and presentations to educate the cell and gene community.
Our experts will also be presenting at several key industry events:
Cell and Gene Meeting on the Mesa, 12-16 Oct 2020
At this renowned event, over 115 cell and gene companies will arrive together virtually to explore a wide range of topics from clinical trial design to scale-up and supply chain platforms for advanced cell therapies.
Allogenic Cell Therapy Summit 26-28 Oct 2020
Rachit Jain, Head of Cell and Gene Therapy, will be presenting on “Roadmap to Digitization in Allogeneic Cell Therapy Process Development and Manufacturing“.
Biomanufacturing World Summit, 16-17 Nov 2020
Körber Pharma will chair the cell and gene manufacturing stream to lead discussions on important topics such as manufacturing, supply chain and operational challenges in developing novel therapies. We are eager to bring our digital manufacturing knowledge to the table and gain pivotal insight from our partners in the industry.
Alliance for Regenerative Medicine (ARM)
The Alliance for Regenerative Medicine is the leading international advocacy organization committed to realizing the promise of regenerative medicines and advanced therapies. We are actively contributing on several ARM committees.
We are honored to support the manufacturing of these modern medicines and share our experiences in support of this noble cause.